Medicare Enrolled

Dr. Bela Ajtai, MD, PHD

Neurology · Amherst, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3980A SHERIDAN DR, Amherst, NY 14226
7162502000
Registered in NPPES since 2007
NPI: 1316155500 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ajtai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ajtai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ajtai

Dr. Bela Ajtai is a neurology specialist in Amherst, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ajtai performed 131,635 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Ajtai received a total of $133,947 from 45 pharmaceutical and/or device companies across 615 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ajtai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 0% volume in NY $133,947 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
131,635
Medicare services
Top 0% in NY for neurology
Not available
Unique patients (not deduplicated)
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 42,560 $38 $65
Vedolizumab infusion (Entyvio)
This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams.
28,515 $16 $26
Ocrelizumab infusion (Ocrevus) for MS 22,806 $46 $86
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
11,705 $26 $128
Injection, eptinezumab-jjmr, 1 mg 8,500 $13 $30
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
6,400 $34 $75
Gadobenate dimeglumine injection
An injection of gadobenate dimeglumine, a contrast agent used to enhance imaging results.
1,335 $1 $7
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
1,283 $0 $6
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
1,109 $16 $53
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
836 $47 $125
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
807 $96 $220
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
637 $4 $7
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
449 $11 $34
Anti-nausea injection (ondansetron/Zofran) 432 $0 $10
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
396 $21 $50
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
380 $1 $2
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
371 $88 $150
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
360 $0 $1
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
317 $0 $2
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
310 $55 $125
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
300 $21 $53
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
214 $1 $3
MRI scan of brain, without contrast
A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves.
169 $142 $607
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
144 $8 $40
New patient office visit, complex (60-74 min) 115 $136 $275
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
112 $2 $14
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
111 $10 $65
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
103 $65 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
102 $109 $225
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 101 $168 $370
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
93 $1 $10
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
76 $55 $185
MRI of brain with and without contrast
An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures.
69 $234 $1,285
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
66 $4 $50
MRI of head blood vessels without contrast
An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye.
58 $160 $615
Platelet aggregation function test
A blood test that measures how well platelets clump together. It evaluates the function of platelets in the blood clotting process.
52 $24 $53
MRI of head blood vessels with and without contrast
An MRI scan that uses contrast dye to create detailed images of the blood vessels in the head, performed both before and after the dye is administered.
40 $241 $1,070
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
40 $6 $19
MRI of upper spine without contrast
An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine.
29 $114 $615
MRI of lower spine, without contrast
A magnetic resonance imaging scan of the lower spinal canal that does not use contrast dye to create detailed images of the spine.
25 $145 $662
MRI of neck blood vessels with and without contrast
This procedure uses magnetic resonance imaging to create detailed pictures of the blood vessels in the neck. Images are taken both before and after the administration of a contrast dye to enhance visibility.
24 $269 $1,070
CT scan of head/brain, without contrast
A CT scan uses X-rays to create detailed images of the head or brain without the use of contrast dye.
21 $78 $271
3D radiographic procedure
A radiographic imaging technique that creates three-dimensional representations of internal structures.
21 $18 $159
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
16 $4 $32
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
13 $6 $6
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $118 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
56.2% high complexity
42.9% medium
0.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$133,947
Total received (2018-2024)
Avg $19,135/year across 7 years
Top 6% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
615
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$99,111
2023
$5,185
2022
$1,647
2021
$21,764
2020
$3,922
2019
$1,428
2018
$889

Payments by company (2024)

Lilly USA, LLC
$74,685
Eisai Inc.
$23,351
ABBVIE INC.
$232
Otsuka America Pharmaceutical, Inc.
$218
PFIZER INC.
$178
UCB, Inc.
$112
Teva Pharmaceuticals USA, Inc.
$77
Kyowa Kirin, Inc.
$50
Alexion Pharmaceuticals, Inc.
$45
Neurocrine Biosciences, Inc.
$43
Lundbeck LLC
$40
GE HEALTHCARE
$28
CATALYST PHARMACEUTICALS, INC.
$21
Alnylam Pharmaceuticals Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
Top 3 companies account for 99.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$74,786
Eisai Inc.
$23,367
Biogen, Inc.
$23,249
US Oncology Corporate, Inc.
$1,752
Corium, LLC
$1,723
Avanir Pharmaceuticals, Inc.
$1,448
Teva Pharmaceuticals USA, Inc.
$1,442
PFIZER INC.
$697
ACADIA Pharmaceuticals Inc
$551
Otsuka America Pharmaceutical, Inc.
$483
AbbVie Inc.
$460
Novartis Pharmaceuticals Corporation
$460
Kyowa Kirin, Inc.
$400
Amgen Inc.
$371
Adamas Pharmaceuticals, Inc.
$317
ABBVIE INC.
$308
Neurocrine Biosciences, Inc.
$303
Lundbeck LLC
$264
Alexion Pharmaceuticals, Inc.
$234
UCB, Inc.
$212
Alnylam Pharmaceuticals Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$126
ARBOR PHARMACEUTICALS, INC.
$110
Biohaven Pharmaceutical Holding Company Ltd.
$84
E.R. Squibb & Sons, L.L.C.
$81
GE HealthCare
$55
US WorldMeds, LLC
$54
Biohaven Pharmaceuticals, Inc.
$53
GlaxoSmithKline, LLC.
$52
MITSUBISHI TANABE PHARMA AMERICA, INC.
$50
AstraZeneca Pharmaceuticals LP
$43
Allergan, Inc.
$42
Impax Laboratories, Inc.
$34
GE HEALTHCARE
$31
Boston Scientific Corporation
$30
Abbott Laboratories
$22
CATALYST PHARMACEUTICALS, INC.
$21
Bayer HealthCare Pharmaceuticals Inc.
$16
Alkermes, Inc.
$14
Janssen Biotech, Inc.
$13
CSL Behring
$13
Mitsubishi Tanabe Pharma America, Inc.
$13
GENZYME CORPORATION
$12
Allergan Inc.
$11
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 90.6% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPLATZER TALISMAN · AMYVID · APOKYN · ARISTADA · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BRILINTA · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · ELIQUIS · EMGALITY · FIRDAPSE · GOCOVRI · Hizentra · Horizant · INFLECTRA · INGREZZA · KISUNLA · Leqembi · MYOBLOC · NAMZARIC · NORTHERA · NOURIANZ · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ORENCIA · Ongentys · PANZYGA · QULIPTA · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Repatha · Rystiggo · SOLIRIS · STELARA · Soliris · TECFIDERA · TRINTELLIX · Trintellix · UBRELVY · ULTOMIRIS · VYEPTI · WATCHMAN Access System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Amherst?
Compare neurologists in the Amherst area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
73
County median income
$71,175
Nearest hospital to ZIP centroid (approximate)
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ajtai is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ajtai experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. Ajtai performed 42,560 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ajtai receive payments from pharmaceutical companies?
Yes. Dr. Ajtai received a total of $133,947 from 45 companies across 615 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ajtai's costs compare to other neurologists in Amherst?
Dr. Ajtai's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ajtai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →